Coherent Corp shares fell 6.20% on June 16 even as the company signed a letter of intent for up to $50 million in direct funding under the U.S. CHIPS and Science Act to expand an indium phosphide semiconductor facility in Texas.
The drop outpaced a broader Technology Equipment sector decline of 2.09% that day, leaving Coherent as an underperformer despite a funding announcement that was outwardly positive. Many institutional and retail investors locked in gains after the Texas expansion news; the stock had already surged 376.7% over the past year and rose 55.6% in the past three months, so profit-taking was a plausible immediate driver.
Numbers underline why investors reacted: Coherent traded at a 12-month forward price-to-earnings multiple of 48.27X versus an industry average of 21.76X, and the company’s free cash flow has slipped into negative territory. As of the end of March 2026, free cash flow was negative $383 million, and capital expenditures reached $290 million by the end of the third quarter of fiscal 2026 — figures that make a $50 million CHIPS award relatively modest against an aggressive build-out.
Operationally the company is not without momentum. Third-quarter fiscal 2026 results showed gross margin expansion of 71 basis points sequentially and 243 basis points year over year; operating margin rose 20 basis points sequentially and 633 basis points year over year. Annual revenue stood at $5.81 billion, even as Coherent reported a net loss of $80.56 million. Analysts remain largely bullish: multiple firms rated the stock Buy over the past month, with an average price target of $380.07, a high of $465 and a low of $230.
Those fundamental gains are tempered by two market realities that help explain the same-day sell-off. First, a recent independent research report questioned the immediate adoption timeline for next-generation co-packaged optics, citing yield issues and integration complexities; that report had already triggered a sharp sector-wide pullback in optical networking stocks earlier in the month. Second, Coherent’s share price carries a premium that has invited profit-taking — the stock’s year-long rally of 376.7% versus an industry gain of 8.3% left it very exposed to short-term corrections.
The firm’s cash position has been cushioned by a prior multi-billion-dollar equity investment from Nvidia, which helped offset cash burn while Coherent scaled manufacturing. Still, the company has invested heavily to scale up production capacity, a push that has pushed free cash flow negative and made incremental federal support appear small in the context of overall capital needs.
Market metrics paint a mixed picture. Coherent’s PEG ratio of 1.03 is slightly below the industry’s 1.12, and Zacks Consensus Estimates for 2026 and 2027 earnings have risen 1.7% and 10.1% over the past 60 days; the company carries a Zacks Rank #3 and a Value Score of D. That blend — accelerating earnings expectations, improving margins, and stretched valuation — can prompt divergent investor reactions when a fresh piece of news lands.
The friction — federal funding support announced the same day the stock fell 6.20% — highlights the open question investors will now watch: how much of Coherent’s decline was a technical unwind of outsized gains and valuation pressure, and how much reflected renewed sector skepticism after the independent research note and a broader pullback in high-growth tech and semiconductor names? The company’s next clarity points will come from operational updates on Texas yield and integration work, future capital deployment plans, and any revised guidance; until those emerge, the market’s split verdict on valuation versus fundamentals is likely to persist.
